Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

news

Christopher Nicholas, PhD
News
Psychedelics Show Potential to Improve SUD Treatment Outcomes
10/31/2023
Tom Valentino, Digital Managing Editor
With drug overdose deaths continuing to climb, Sana Symposium presenter Christopher Nicholas, PhD, said studies suggest that incorporating the use of psychedelics into treatment modalities could improve outcomes.
With drug overdose deaths continuing to climb, Sana Symposium presenter Christopher Nicholas, PhD, said studies suggest that incorporating the use of psychedelics into treatment modalities could improve outcomes.
With drug overdose deaths...
10/31/2023
Psych Congress Network
Christopher Nicholas, PhD
News
Psychedelics Show Potential to Improve SUD Treatment Outcomes
10/31/2023
Tom Valentino, Digital Managing Editor
With drug overdose deaths continuing to climb, Sana Symposium presenter Christopher Nicholas, PhD, said studies suggest that incorporating the use of psychedelics into treatment modalities could improve outcomes.
With drug overdose deaths continuing to climb, Sana Symposium presenter Christopher Nicholas, PhD, said studies suggest that incorporating the use of psychedelics into treatment modalities could improve outcomes.
With drug overdose deaths...
10/31/2023
Psych Congress Network
Andrew Penn, RN, PMHNP, and Charles Raison, MD
News
Studies Illustrate Potential of MDMA-, Psilocybin-Assisted Therapies
10/30/2023
Tom Valentino, Digital Managing Editor
Andrew Penn, RN, PMHNP, and Charles Raison, MD, shared findings from late-stage trials for MDMA-assisted therapy to treat post-traumatic stress disorder and the use of psilocybin for treatment-resistant depression and major depressive...
Andrew Penn, RN, PMHNP, and Charles Raison, MD, shared findings from late-stage trials for MDMA-assisted therapy to treat post-traumatic stress disorder and the use of psilocybin for treatment-resistant depression and major depressive...
Andrew Penn, RN, PMHNP, and...
10/30/2023
Psych Congress Network
Single-Dose Psilocybin Linked With Rapid, Sustained Gains in Patients With MDD
News
Single-Dose Psilocybin Linked With Rapid, Sustained Gains in Patients With MDD
09/18/2023
Jolynn Tumolo
A single 25-mg dose of psilocybin plus psychological support was associated with an improvement in depressive symptoms compared with active placebo in adults with MDD, according to a study published in JAMA.
A single 25-mg dose of psilocybin plus psychological support was associated with an improvement in depressive symptoms compared with active placebo in adults with MDD, according to a study published in JAMA.
A single 25-mg dose of...
09/18/2023
Psych Congress Network
News
Experts Share 2 Top Tools for Peer Support in Psychedelics
10/14/2022
Evi Arthur
Techniques to make this therapeutic tool more effective and help build connection with patients.
Techniques to make this therapeutic tool more effective and help build connection with patients.
Techniques to make this...
10/14/2022
Psych Congress Network
News
Lynn-Marie Morski and Rosalind Watts, Most Influential Women in Psychedelics
02/22/2022
Heather Flint, Senior Digital Managing Editor
Sana Symposium Steering Committee Members, Lynn-Marie Morski, MD, JD, and Rosalind Watts, MD, named 2 of the 16 most influential women in the psychedelic space.
Sana Symposium Steering Committee Members, Lynn-Marie Morski, MD, JD, and Rosalind Watts, MD, named 2 of the 16 most influential women in the psychedelic space.
Sana Symposium Steering...
02/22/2022
Psych Congress Network
News
Lynn-Marie Morski and Rosalind Watts, Most Influential Women in Psychedelics
02/22/2022
Heather Flint, Senior Digital Managing Editor
Sana Symposium Steering Committee Members, Lynn-Marie Morski, MD, JD, and Rosalind Watts, MD, named 2 of the 16 most influential women in the psychedelic space.
Sana Symposium Steering Committee Members, Lynn-Marie Morski, MD, JD, and Rosalind Watts, MD, named 2 of the 16 most influential women in the psychedelic space.
Sana Symposium Steering...
02/22/2022
Psych Congress Network
News
Psychedelic-Assisted Therapies are Gaining Ground and Attention
09/29/2021
Heather Flint, Senior Digital Managing Editor
Psychedelic-assisted therapy is an emerging treatment that is gaining traction and attention.
Psychedelic-assisted therapy is an emerging treatment that is gaining traction and attention.
Psychedelic-assisted therapy is...
09/29/2021
Psych Congress Network
News
Psychedelic-Assisted Therapies are Gaining Ground and Attention
09/29/2021
Heather Flint, Senior Digital Managing Editor
Psychedelic-assisted therapy is an emerging treatment that is gaining traction and attention.
Psychedelic-assisted therapy is an emerging treatment that is gaining traction and attention.
Psychedelic-assisted therapy is...
09/29/2021
Psych Congress Network
News
Sana Symposium Recap: New Treatment Potential and Future Possibilities of Psychedelics
09/19/2021
Meagan Thistle
This weekend’s 3-day Inaugural Sana Symposium guided virtual attendees through the preparation, journey, and integration of psychedelic therapies.
This weekend’s 3-day Inaugural Sana Symposium guided virtual attendees through the preparation, journey, and integration of psychedelic therapies.
This weekend’s 3-day Inaugural...
09/19/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Popular Now

News
Increased Use of LAIs Could Improve Schizophrenia Outcomes, Meta-Analysis Finds
04/20/2021
For the maintenance treatment of schizophrenia, long-acting injectable antipsychotics (LAIs) were associated with a lower risk of hospitalization or relapse than oral antipsychotics in a comparative meta-analysis of 137 studies spanning 3...
For the maintenance treatment of schizophrenia, long-acting injectable antipsychotics (LAIs) were associated with a lower risk of hospitalization or relapse than oral antipsychotics in a comparative meta-analysis of 137 studies spanning 3...
For the maintenance treatment of...
04/20/2021
Psychiatry & Behavioral Health
News
The Bystander: A First-Person Perspective on Being Blind to Tardive Dyskinesia
06/15/2021

 

 

   
In the “TD360” presentation at the 2018 Psych Congress meeting, Dr. Rakesh Jain passionately challenged the audience to “not walk away” from acknowledging that we all have patients with tardive dyskinesia (TD). This struck close to home for...
In the “TD360” presentation at the 2018 Psych Congress meeting, Dr. Rakesh Jain passionately challenged the audience to “not walk away” from acknowledging that we all have patients with tardive dyskinesia (TD). This struck close to home for...
In the “TD360” presentation at...
06/15/2021
Psychiatry & Behavioral Health
Education
Continuing Education: Excessive Daytime Sleepiness: Clinical Considerations for Patients with Comorbid Psychiatric Disorders
07/01/2021
07/01/2021
Psychiatry & Behavioral Health
News
Warm Handoff Eases Transition to Mental Health Care Services, Study Finds
08/03/2021
A warm handoff or transfer of care between a primary care physician and mental health provider can help improve access to mental health services for children and their families, new study suggests.
A warm handoff or transfer of care between a primary care physician and mental health provider can help improve access to mental health services for children and their families, new study suggests.
A warm handoff or transfer of...
08/03/2021
Psych Congress Network
Vlad and Ann
Videos
Discussing Comorbid Disorders and Complex ADHD
09/08/2021
In the final part of this series Ann Childress, MD, and Vladimir Maletic, MD, MS, discuss treatment techniques for complex ADHD and diagnosis of comorbid ADHD.
In the final part of this series Ann Childress, MD, and Vladimir Maletic, MD, MS, discuss treatment techniques for complex ADHD and diagnosis of comorbid ADHD.
In the final part of this series...
09/08/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Sign Up

Psychiatry & Behavioral Health Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use